New Key Statistics Module, Z-Score and F-Score
HKSE:01513 Key Ratios
Market Cap HK$ M | 31,981.30 |
Enterprise Value HK$ M | 23,612.99 |
P/E(ttm) | 10.75 |
PE Ratio without NRI | 9.59 |
Forward PE Ratio | 8.89 |
Price/Book | 2.37 |
Price/Sales | 2.75 |
Price/Free Cash Flow | 11.62 |
Price/Owner Earnings | 26.25 |
Payout Ratio % | -- |
Revenue (TTM) HK$ M | 13,010.00 |
EPS (TTM) HK$ | 2.33 |
Beneish M-Score | -2.84 |
10-y EBITDA Growth Rate % | 13.20 |
5-y EBITDA Growth Rate % | 12.70 |
y-y EBITDA Growth Rate % | 6.30 |
EV-to-EBIT | 8.23 |
EV-to-EBITDA | 8.23 |
PEG | 0.76 |
Shares Outstanding M | 926.50 |
Net Margin (%) | 16.55 |
Operating Margin % | 21.44 |
Pre-tax Margin (%) | 21.36 |
Quick Ratio | 1.60 |
Current Ratio | 1.81 |
ROA % (ttm) | 7.88 |
ROE % (ttm) | 14.29 |
ROIC % (ttm) | 20.09 |
Dividend Yield % | 5.95 |
Altman Z-Score | 3.36 |
HKSE:01513 Number of Guru Trades
HKSE:01513 Volume of Guru Trades
Gurus Latest Trades with HKSE:01513
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
HKSE:01513 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Livzon Pharmaceutical Group Inc Insider Transactions
No Available Data